Goldman Sachs’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-30,000
| Closed | -$9.78M | – | 6313 |
|
|
2025
Q2 | $9.78M | Buy |
30,000
+14,000
| +88% | +$3.87M | ﹤0.01% | 2779 |
|
|
2025
Q1 | $4.32M | Buy |
+16,000
| New | +$4.11M | ﹤0.01% | 3503 |
|
|
2024
Q2 | – | Sell |
-25,000
| Closed | -$3.74M | – | 5632 |
|
|
2024
Q1 | $3.74M | Buy |
+25,000
| New | +$4.17M | ﹤0.01% | 3366 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$4.01M | – | 5727 |
|
|
2023
Q1 | $4.01M | Buy |
+20,000
| New | +$4.2M | ﹤0.01% | 3256 |
|
|
2021
Q4 | – | Sell |
-4,000
| Closed | -$755K | – | 6444 |
|
|
2021
Q3 | $755K | Sell |
4,000
-25,000
| -86% | -$4.69M | ﹤0.01% | 4948 |
|
|
2021
Q2 | $4.92M | Sell |
29,000
-1,000
| -3% | -$146K | ﹤0.01% | 3352 |
|
|
2021
Q1 | $4.24M | Sell |
30,000
-10,000
| -25% | -$1.5M | ﹤0.01% | 3289 |
|
|
2020
Q4 | $5.2M | Buy |
+40,000
| New | +$5.34M | ﹤0.01% | 2971 |
|
|
2020
Q1 | – | Sell |
-34,700
| Closed | -$4M | – | 5193 |
|
|
2019
Q4 | $4M | Buy |
34,700
+21,100
| +155% | +$2.1M | ﹤0.01% | 3140 |
|
|
2019
Q3 | $1.09M | Hold |
13,600
| – | – | ﹤0.01% | 3970 |
|
|
2019
Q2 | $987K | Hold |
13,600
| – | – | ﹤0.01% | 4004 |
|
|
2019
Q1 | $1.27M | Hold |
13,600
| – | – | ﹤0.01% | 3919 |
|
|
2018
Q4 | $992K | Hold |
13,600
| – | – | ﹤0.01% | 3974 |
|
|
2018
Q3 | $1.19M | Sell |
13,600
-50,000
| -79% | -$5.03M | ﹤0.01% | 3939 |
|
|
2018
Q2 | $6.26M | Buy |
+63,600
| New | +$6.31M | ﹤0.01% | 2804 |
|
|
2018
Q1 | – | Sell |
-12,600
| Closed | -$1.6M | – | 5877 |
|
|
2017
Q4 | $1.6M | Sell |
12,600
-20,000
| -61% | -$2.51M | ﹤0.01% | 3959 |
|
|
2017
Q3 | $3.83M | Buy |
32,600
+20,000
| +159% | +$1.71M | ﹤0.01% | 3404 |
|
|
2017
Q2 | $1M | Buy |
12,600
+4,000
| +47% | +$256K | ﹤0.01% | 4451 |
|
|
2017
Q1 | $441K | Hold |
8,600
| – | – | ﹤0.01% | 5139 |
|
|
2016
Q4 | $322K | Sell |
8,600
-11,400
| -57% | -$477K | ﹤0.01% | 5432 |
|
|
2016
Q3 | $1.36M | Sell |
20,000
-115,500
| -85% | -$8.15M | ﹤0.01% | 4134 |
|
|
2016
Q2 | $7.52M | Sell |
135,500
-57,300
| -30% | -$3.61M | ﹤0.01% | 2543 |
|
|
2016
Q1 | $12.1M | Buy |
192,800
+152,800
| +382% | +$10.2M | 0.01% | 2084 |
|
|
2015
Q4 | $3.77M | Sell |
40,000
-10,000
| -20% | -$927K | ﹤0.01% | 3099 |
|
|
2015
Q3 | $4.02M | Sell |
50,000
-18,900
| -27% | -$2.1M | ﹤0.01% | 3078 |
|
|
2015
Q2 | $8.26M | Sell |
68,900
-10,500
| -13% | -$1.25M | ﹤0.01% | 2500 |
|
|
2015
Q1 | $8.29M | Buy |
79,400
+39,700
| +100% | +$4.02M | ﹤0.01% | 2456 |
|
|
2014
Q4 | $3.85M | Sell |
39,700
-158,300
| -80% | -$14.7M | ﹤0.01% | 3235 |
|
|
2014
Q3 | $15.5M | Buy |
198,000
+40,000
| +25% | +$2.58M | 0.01% | 2007 |
|
|
2014
Q2 | $9.98M | Buy |
+158,000
| New | +$9.39M | ﹤0.01% | 2370 |
|
|
2013
Q4 | – | Sell |
-119,400
| Closed | -$7.64M | – | 6639 |
|
|
2013
Q3 | $7.64M | Buy |
+119,400
| New | +$5.95M | ﹤0.01% | 2520 |
|
Other funds holding ALNY
VPM
VCM
